I guess now pretty much everyone has jumped aboard the Marijuana bandwagon — the Motley Fool is a bit later to the party, having just announced its Marijuana Masters investing service ($1,499, no refunds), helmed by David Kretzmann (a new name to me), so let’s see what it is that the typically much more mainstream Foolies are pitching…
“Tom Gardner’s favorite marijuana stock is up 215% in the past year…
“And we think it’s just getting started
“Read on to learn more about the little company Tom compares to Shopify… and how you can secure instant access to my top 10 marijuana BUY recommendations!”
And apparently they’re starting off with a 10-stock marijuana portfolio…
“Today, I have 10 official marijuana BUY recommendations waiting for you directly inside Marijuana Masters.
“One of which was actually brought to my attention by Tom Gardner himself.
“In fact, it’s Tom’s No. 1 marijuana company in the world at the moment.”
So what else do we learn about it? Apparently Kretzmann has dug into Tom’s idea and likes it…
“But knowing just how bullish Tom was on this tiny marijuana stock, I dug into the company’s financials and decided it deserved a spot among our initial 10 official recommendations inside Marijuana Masters.
“Tom calls this stock a ‘first mover’ with ‘a great balance sheet’ that compares to Shopify, a favorite stock of his that’s returned 408% since he first recommended it in July 2016. Of course, we can’t promise performance like that for this recommendation, but this stock leaves us with lots of reasons to feel bullish.”
Any other clues?
“With inside ownership above 30% and dedicated co-founders still at the helm, I’m personally convinced that this company can turn its early lead in this space into a long-lasting competitive advantage as it expands the scope of its products and scale of distribution.”
We also get a little taste of Kretzmann’s big picture enthusiasm…
“… why now?
“As you may know, on Oct. 17, Canada will become the first major country to legalize recreational marijuana on a national level. Which means, just two weeks from today, Canadians will literally be able to walk into a store and purchase cannabis just as if it were beer.
“And then right on the heels of that are the U.S. midterm elections on Nov. 6. Four states are voting on marijuana laws, and many others have bills in progress whose fate could be determined by the election’s outcome.
“With these two major catalysts at hand, I believe this is a decisive moment for investors like us.”
So… what’s the stock? Here are the rest of our hints:
“Marijuana Masters Pure Play Stock #1 – ‘The Amazon.com of Marijuana’
“Just like Amazon.com, this company aims to be ‘your everything cannabis store.'”
And a few more details…
“With a whopping 32 different e-commerce sites operating across 20 countries, and 1.5 million users in its database, it’s already one of the most popular cannabis brands out there.
“And that doesn’t even take into account its telemedicine app, which allows individuals to receive online video consultations with licensed health care professionals and obtain a medical marijuana prescription.”
The stock is apparently up 1,200%, too… though that doesn’t necessarily make them stand out as a marijuana stock, not in a sector where nuttiness is the new normal (at least for now), and they seem to be monkeying around with time periods a bit if they’re describing it as having risen both 215% and 1,200%.
Any other clues?
We do get this:
“… the most exciting part of the ‘Amazon.com of Marijuana’ is it’s on the brink of becoming the first company to sell cannabis via an online marketplace.”
So who is it? Thinkolator sez this must be: Namaste Technologies (N.V in Toronto, NXTTF OTC in the US), which is trying to build a marketplace first for medical marijuana then, perhaps, for recreational retail sales in the future. They do indeed match those clues, claiming 32 e-commerce sites in 20 countries and a 1.5 million user database, along with a Teladoc-like medical consultation service (NamasteMD) that lets you get your medical marijuana prescription with a virtual doctor visit, and the Shopify and Amazon comparisons make some sense given Namaste’s focus on growing an e-commerce platform for Canadian medical marijuana (though plenty of companies are talking about using Shopify itself to build their own marijuana stores, too).
There has been a lot of controversy over Namaste recently, moreso even than the other richly-valued marijuana stocks, mostly because management has done some really dumb things (particularly hosting a wild party for shareholders who pledged not to sell for 90 days… even as executives were reportedly selling shares)… and Andrew Left at Citron Research has a very aggressive short/fraud analysis out there right now, so if you’re going to consider Namaste, you should at least review his short thesis and Namaste’s response. I don’t know if Tom Gardner still likes the stock or has an opinion on the controversy, but clearly David Kretzmann is a fan at current prices.
If you want to read those competing reports, Citron’s two fraud allegations and the argument that Namaste will never get a Nasdaq listing (and might be delisted by the TSXV) and should be worth about 25 cents a share are here and here, and Namaste’s response is here.
Andrew Left is a bit of a blowhard, to be sure, and pushes his arguments very aggressively without always being right… but he’s also a short seller, so he’s careful with his facts and has a lot more at risk than I do, so I take his arguments seriously. And in this case, frankly, his accusations are a lot more compelling than the company’s tepid and pretty generic “nuh uh, we didn’t do anything wrong” response. That doesn’t mean Namaste is definitely a fraud, but I don’t see a lot to make them compelling compared to other Canadian marijuana companies, and I don’t like most of the rest of them at current prices, either… so it does mean that it costs me nothing to not buy the shares, and that’s what I’ll be doing.
The positive thing, I suppose, is that this isn’t a grower… they do have some kind of investment in a growing operation, and they primarily sell vaping supplies right now, but their goal is to be an e-commerce leader in medical marijuana, and essentially an online retailer of marijuana that’s produced by other companies — so they might not be as impacted by fluctuating wholesale prices in the early years as the growers could be (particularly the smaller or higher-cost growers)… but then they also will presumably have difficulty in establishing their own brands, since they won’t control their inputs, and they do need good grower relationships (Tilray dropped them, for example, after Namaste got in trouble with Canadian regulators over their marketing and their stupid “pledge party” a few weeks ago).
The goal of turning their CannMart e-commerce platform into the “next Amazon” is a delightfully lofty one, but there were hundreds of “might become Amazons” in the mid-1990s, and most of them aren’t with us any more, so be careful about how much survivorship bias you use in your rear-view mirror. Amazon itself might not have made it if they didn’t get a big chunk of financing right before the dot com crash. (If that’s before your memory, they did a $1.25 billion convertible bond financing in 1999 that lots of people thought was crazy at the time, not long before experiencing a 90%ish fall in the stock price.)
There are a few other ideas teased in the ad, but that’s the match for “Tom Gardner’s favorite” … I’ll see if I can dig up those other answers for you, but, as you’re probably well aware, I’m not all that enthusiastic about most of these companies at this point — is the Motley Fool’s decision to enter the space just another opportunistic publishing gambit, or does it mean that marijuana is ready to really go mainstream as an investment?
You’ll have to make your own call on that, but when it comes to my portfolio I’m being very cautious in this space. The business overall will clearly be quite large and the top line numbers will probably grow quickly if there isn’t a major regulatory setback in the US, but there’s a lot of junk out there… and in the closely-watched Canadian market we’ve got a massively financed and enthusiastic industry that’s perfectly capable of wildly overproducing and crushing wholesale prices for growers. Most of these dozens of heavily hyped companies probably won’t exist in a few years, or will be shadows of their current selves, so if you’re investing in the sector make sure to understand what makes your company financially viable or likely to succeed — part of that calculation will just be financing, the companies that raise hundreds of millions of dollars at these rich valuations will survive a downfall more easily because they’ll have enough money to make payroll when stock prices hit a soft spot, but predicting the actual eventual victors who have the best retail presence or the best brands or the lowest cost structure probably requires a lot of foresight and luck at this point.
And if you’ve got thoughts to share on your favorite, or want to challenge Tom Gardner to a virtual marijuana stock duel on this point, well, feel free to comment below.
Disclosure: I own shares of Shopify, Amazon and Teladoc among the companies mentioned above. I will not trade in any covered stock for at least three days after publication, per Stock Gumshoe’s trading rules.
I believe the Thinkolator is spot on. You would have thought Motley Fool would have done a lot more research and come up with some other stock(s) to promote for their new service. I would not buy the subscription service, do your own research – including right here at Stock Gumshoe – use the search field, nor would I buy Namaste.
I subscribed to the Fool newsletter for awhile. I lost money on every one of the stocks I got on their advice. No thank you.
As did I. Still hurting from the under Armor recommendation
Head bent hat in hand, he said, “As am I”. The former fool, said.
Stitch fix got me.
I’m watching my Stitch Fix rec grow slowly but surely.
how long did you hold each position on average?
I achieved over 100% portfolio growth in 2 years with their stock recommendations. I found their reports worth it. Thanks Motley Fool!
100% correct.
The best pot stocks will be the ones the gurus miss. Better off putting your $1500 toward a few well researched names the you find fascinating.
I find it hard to believe that MF is mentioning Nemaste as a stock and wants someone to pay $1500 for their ghost best pot stock.
I bucked MF long ago and bought CROX at $4 while MF was busy bashing it.
Look who lost out.
Today, I would put mt $1500 into TRXC and wait forever to double it instead.
No thanks. TRXC is over-hyped and ready for a big short.
What’s the relevance to TRXC in this disucssion?
Come on, there is a direct correlation between robotic surgical devices and pot stocks. Everyone knows that.
Join the discussionThe Dr.s too busy smoking so the robots have to take over.
I agree. No to Namaste. There are better places to invest. I just consolidated 18 positions into 13, and have substantial capital in the space.
There are only two “blue chips”. That’s Canopy Growth CGC and Aurora ACBFF. Of the two CGC has run fast and hard. ACBFF has not, but appears poised to. With a strategy of global dominance, a deep focus on CBD, and the near-term catslydt of a US stock listing on NYSE in late October, ACBFF is the one to buy.
Aphria APHQF is arguably third in line, and definitely one to own, no US listing yet, but they’ve made all the moves that would preclude one, and just recently. I see it happening soon.
For US pure play exposure with top management team and deep ties to Aphria, I like Liberty Health Sciences LHSIF the best.
A player in its own right and expanding globally is Organigram OGRMF. They are a top quality “organic” play in the space. I fully expect OGRMF to be acquired, and st a premium. Strong company and brand.
The last one I’ll mention is Auxly Cannabis Group CBWTF. This “streaming play” is like a cannabis streaming company combined with a financially savvy investment firm but who are also building out a complete ecosystem of partnerships. It’s almost like owning a cannabis ETF, and this company is unique in the space. At some point, I’m expecting a good sized dividend, but that’s just conjecture at this point,
If you’re interested in buying a cryptocurrency that’s deeply aligned to the cannabis space, that’s DASH. Thrir partnership with Alt36 is important. They have first mover advantage in the US.
There are many others and everyone has their own opinions. I’m heavily invested in all of these, and I feel they are all top-tier leaders. Good investing.
I am doing more or less the same as CryptoInvestor, but probably in not the same volume. But like him, I agree the big two are Canopy and Aurora, and that’s where most of my pot money is. Like him, I recently just weeded down my holdings from 11 to 5. My third largest is Cronos, but I do agree with him that Aphria is solidly up there as well. I did own Aphria early on and sold for a modest profit, but think the time has come to buy some again on dips. My most recent purchase, just a few days ago, is CannaRoyalty, a company that is not a grower, but lends money to pot companies in return for a percentage of revenue, or an equity position. I also have a buy order in for Organigram, another one that CryptoInvestor likes. Both of those are fairly new to me, but the more I read about them, the more interested I have become. They have been mentioned more and more in the various weed websites. As to TMF and their pitch for Namaste, forget it! Thanks again, Travis!
Sweet pun you made there, gthorne.
Fantastic post, thanks for your insight.
a
Good insights, thanks for the post.
Travis you are a gem!! (i know, its nothing new). I think when constellation brands (stz) made a bet on Canopy, the whole industry became official and legit. They are a fortune 500 company, with a industry that is being threatened by the cannabis industry. I’m not smart enough to know which Marijuana stock will be the big winner in the end. So i put a very small position in all that make sense to me. so although a few of my marijuana positions are down 50%-60%, the ones that are up 160% make up for them. There are also some ETFs tracking the industry like HMMJ.ca. I think if invested wisely, you can close your eyes for a while and find yourself with 1000% gains in a few years from now!
#CGC #STZ #CBWTF #IIPR #KSHB #LBUY #NXTTF
I hope you’re right! I think the industry is legit, just not sure how legit the investment returns of any of the companies will be if you start at current prices.
I know it’s not exactly a fair comparison, but e-commerce was legit in 1999 and 2000 and clearly had real potential as an industry… but the stocks were foolishly priced — if you had bought the best one, Amazon, anywhere near the peak in 1999 or 2000 you would have had to sit through both a 90% drop and a near decade of recovery before showing gains, something very few people have the confidence or patience to do.
And, of course, lots of people bought lots of other ridiculously priced e-commerce stocks that did far worse than that and no longer exist. An industry can be real and legit and still a terrible investment. I don’t know how it will end, of course, and I’ve already missed some huge returns because I thought these companies were at crazy prices before they gained hundreds of percent more, so I might be too cautious… but that’s the concern I carry into this mania.
Who cares about a FOOL’S opinion ?
My favorite weed stock BAR NON is IIPR.
Very safe concept. Just bought a Michigan property. EXTREMLY low float and…pays DIVIDEND !
It can hardly get better than that.
That’s the only one I own.
I owned it, but sold early. I wish I’d stayed with it. Most of my pot stocks went red today except one. My metals sank too. No worries. Volatile market, but the party is not over yet. I’m confident gold and uranium will pay off in the long run. My silver turned out to be a falling knife, but that should bounce back too. The marijuana stocks are only just starting to run. Midas gold approvals set for May 2020. I expect Barrick will buy them out when the approvals are final.
with a rose, I bought APHQF, HMLSF (dividend), IIPR (dividend), and MMNFF, and also AUY just because I like the yellow stuff.
Well-played on the “with a rose” segue…another long-time DeadHead here…as of 9/21/2018, here are my results:
POTN/Pot Network: loss 70.99%
Aurora Cannabis: gain 260.48%
Aphria: gain 157.91%
Canopy Growth: gain 62.42%
Down on most of my gold stocks also except NSU. Looking at SVM right now with SP down. Also, GSV took a nose dive but will eventually shoot up again. I will not pay MF Marijuana Masters $1,399 for research I can do myself. That’s abuse.
Midas Gold Is Indeed the Best Prospect in Gold Currently due to their Antimony Ore which is the Largest in N. America!
Antimony is utilized in many U.S. Military Projectiles and is an Extremely Rare Mineral!
Me three !!! IIPR pays a dividend, has very low to almost zero capital outlay for maintenance, etc. and does not compete in the Cannabis product itself.
AMEN
Thanks for the mention of IIPR, that was not on my radar, and surprisingly up $2 today when virtually everyone else went down. I am sellling my Namaste ( I had high hopes for their medicinal work but seems as if there corporate values are pretty suspect).
what is the name of this company? cannot find the symbol
are you asking about IIPR? the first two characters are capital i’s, not l’s. Name is Innovation Industrial Properties, a REIT that rents out warehouses for cannabis grow operations in US.
What is the difference between IIPR and IIPR-A?
-A is likely the Preferred shares, which are senior to common equity and have a much higher yield (about 8%, though that’s just going from memory) but are also callable in a few years at $25 so basically just a yield-to-maturity play that should be sensitive primarily to any big changes in near-term interest rate expectations.
I’m just not sure how to feel about Motley Fool. They seem to have some good ideas, but I’m turned off by the way they try to sucker you into multiple services. I did sign up for three years of Rule Breakers, but only because it was a substantial bargain compared to what they usually try to get you to pay. Every time they come up with a new service, they have this round table talking it up and then they tell you their price and how you ought to be amazed at what a value it is. If I remember right, they originally were pricing Marijuana Masters at $3500, but including their Premier Pass to ten other services as part of the deal. Today I got the last chance notice to sign up before they close the service at midnight tonight. Now I can sign up for $1500, but now only Market Pass is included which allows access to Stock Advisor, Rule Breakers, and other research reports. Oh, boy! Nope, think I’ll pass.
Can’t figure out why all the different services. I paid for stock advisor. That will be the last penny they get from me. If I’m paying for stock advisor, I feel I should be getting the best advice on stock. But wait, if I pay more I get better advice? Or, every time something new or hot comes along they put that into another service, charge more money.
If you think your advice is worth more than $100 they should just charge that from the start.
Now they have a new deal on what stocks to buy in any kind of market. As far as I’m concerned they can stick their advice where the sun don’t shine.
Knowing I may not be getting the best advice they can give, I no longer want anything to do with stock advisor.
Yes, the tease is Namaste. I think in the end there will be probably about a half dozen survivors in the MJ space once the dust settles. One of those, in my opinion, will be CannTrust Holdings Inc. They are profitable and growing their patient base in the medical MJ field. Canopy Growth trades at around 150 x sales… Canntrust trades around 40 x sales.
CannTrust has potential. I owned it for awhile. I bought around $7 and sold when it bounced back down from $10. I was a bit concerned when it couldn’t break through the double top there, but I may have been impatient. It’s either to $11 or $8 near-term IMHO. I didn’t know of a catalyst either.
In all honesty, I really just wanted to own more Aurora. I think ACBFF is going from $10 to $20, and maybe by Jan. The US listing may even take it there by Nov.
And I think Aphria is next in line, but no inside info
There is talk in Canada about doing away with medical marijuana once all marijuana sales are legalized. As well, Shoppers Drug Mart, Canada largest drug store chain (and owned by our largest grocer, Loblaws) is applying to sell medical marijuana. If either goes through, a company such as Nameste could be significantly affected and not in a good way.
True, the medical claims might dry up once it’s easy for anyone to buy marijuana without a prescription. There’s still a role for specific strains and targeted uses and secondary “health” products, I’m sure, but I imagine a lot of the “wink wink, here’s a prescription” medical marijuana sales will quickly migrate over to recreational dispensaries or whoever’s cheapest or most convenient.
and what if you can grow it yourself, it is no more difficult than growing tomatos
I could totally grow some crops, keep some livestock, and feed my family. You could too. Those silly grocery stores are probably going out of business real soon, right?
I’m in a sharing mood, so I have to tell you: Cannabis is much more difficult to grow than tomatoes, if you want a good end product. Sure, it is a weed and it grows extremely easily. Like, I can drive a car just fine, but I’m no Ken Block or Travis Pastrana.
The comparison to tomato plants comes from the fact that cannabis and tomatoes can thrive on nearly identical nutrients, and they both love similar acidic soil. That’s the seed that grew into the idea that if you’ve grown tomatoes, you can easily grow pot, but it is just not true.
Growing good tasty smoke is vastly more difficult. Tomatoes… don’t over water it. Don’t use too much manure at the end of your season, or they’ll taste green the next season from too much nitrogen left over. Taper your nutrients down as the fruit grows, then to nothing for a week or two at the end… I like to, at least. They auto flower and produce fruit with no change in light cycle or nutrients. An idiot could grow tomatoes, with very little instruction.
Now, if you’ve got some time, I could show and teach you how to grow excellent shit. Or, you could spend about 500 times longer than it took me to write this post, just researching online. Then there’s a good chance you’d still grow garbage anyway.
Look at the legal states, and compare what they churn out to stuff from the 90s into early 2000s. It’s like an artisanal handmade product that got outsourced to China. It’s all about volume now, because variety sells far more than if they had just a few solid awesome strains. The point of me saying this part is that cannabis is a learning game in regards to what conditions are optimal for various strains. Your first crop may be good, but over time it’s always going to get better as you learn what tweaks you can add in. Suppliers in legal states don’t bother getting all cozy with something over time until it’s perfect, it’s all about variety, volume, and that paper. Good smoke takes time and dedication. Every day you work on it.
If you’ve got automatic sprinklers, just fertilize tomatoes lightly once or twice a week, support them with a tomato cage, then pick ’em when they are done.
I grew tomatoes from seed when I was seven years old. I have not grown pot for well over 20 years. I was young and dumb, but that’s an entirely different other story.
No way would I bet against Andrew Left. His shorting record is formidable
He does a good job, usually… not necessarily when he’s shorting just because “it’s too expensive,” since that’s a tough battle, but when he goes after bad behavior and alleges fraud I wouldn’t stand in his way.
Andrew called for a short on SHOP a little more than a year ago, with some nasty allegations. Nothing really came from it.
Good point. I disagreed with him on that one (he argued that they were inflating numbers through aggressive affiliate marketing and not disclosing how many of their customers churned out quickly and disappeared, which was partly true but, I think, exaggerated), and I still hold SHOP.
I bought CVSI at the same time left was filing his lawsuit, still waiting for it to come back!
Really. Take a look at Chemours (CC) and Transdigm (TDG). There are plenty more.
Left identified INGN as his next short target, May 24 when it was at 170. It momentarily dropped to 157 but then went on to peak at 278 before falling to current 210. So I do with Citron what I used to do with Zacks, act contrary to their recommendation.
I just saw that there is a class action lawsuit filed today against Namaste. It says the company made false and misleading statements. This cannot be a good thing for the stock. TVRN is tanking 65% today because of a class action suit and doubts brought to light from the FDA. I for one am staying away from NXTTF.
Pretty much any stock that has any controversy and a sharp drop in the share price ends up with class action lawyers circulating press releases and trying to gin up a “class” to file a lawsuit. That doesn’t mean some of them aren’t real, or that Namaste isn’t in real trouble this time (I don’t know), but most of the lawsuits don’t end up materializing.
IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Namaste Technologies Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
BusinessWire
I have been so well served by TMF that I have to state my positive bias, since others have stated their negative bias. First, no one gets them all right and if they say they do, we all know they are BS’ing. But I’ve found TMF to be the most transparent, honest and hard working bunch of the over 2 dozen services I have tried over the years.
That said, I think Tom Gardner hasn’t made a good choice here and I say that cautiously since so many times in the past I disagreed and I turned out to be the wrong one. But re: Namaste, even if Citron is wrong about their fraud(s), there are others out there with better business plans so why wrestle with NXTTF?
TMF is like a marriage. You don’t pick and choose traits of your mate and then toss them aside since we all have negatives. You must look at the total picture before judging. TMF has less negatives than the others and have built a terrific corporate culture that favors the subscribers and gives you the best shot and honest evaluations and analyses of finely researched companies.
Don’t bother trashing me on this, as I am now biased in their camp.
M
Thanks, feedback always appreciated — it doesn’t have to be negative 🙂
I do have a lot of respect for the Gardner brothers and their basic services like Stock Advisor, which are inexpensive and have plenty of fans in our readership and have built up excellent records mostly because they don’t easily sell or force themselves to hold only a small number of stocks — but I also hear frustration from folks who subscribe to Stock Advisor, for example, and buy a few of their worse picks instead of a few of their better ones — with 100+ stocks actively “recommended” sometimes folks buy what end up being the wrong ones and get frustrated (if you held Priceline or Netflix for a few years on their recommendation, you were probably delighted — if you instead opted for The Container Store or Rosetta Stone, you probably feel much different).
I haven’t heard as many good things about their pricier portfolio or specialty services, don’t know what the performance of those is like.
I will add that I am a long-term subscriber to the MF Pro and Options services, which have gotten a bit pricier on the latest re-up. They have made some unfriendly changes (to subscribers) to their comment boards and some other things, but overall Jeff Fischer runs a tight ship with these two services, and I have been quite happy with them, with my results, and with the education I have received over the years (especially with respect to Options). I ignore ALL other hype and sales nonsense from Motley Fool for other services.
This is a business there will he sales nonsense and I looked before I bought in bought in about their opt out policy. Then I bought in.
I subscribed to mf marijuana maverick in Canada about 3 months ago. Set up an account just for mj. Put 40000 in and I’m at 65000 today (was over 69 a week ago). I’m a mf fan! I should add that I have 7 of my own picks in there. The mf stocks have worked well. 3 doubled and I sold half. Namaste tripled so fast that I didn’t sell half soon enough and had a better return. If nothing else I should be able to pay subscriptions for a decade or two.
I have been investing 25 years used to be a licensed broker, and also have been so very well served by the Motley Fool I am delighted. They are transparent and most all of their services have beaten the market by impressive margins. They had a rough time in the dot-com bubble, but admitted it. As we know, they put out teasers to get new interest, but once you read their advice, almost all of it tends towards buying a portfolio of quality growth companies with good leadership. (Offering this new service is weird and out of character for MF to me, i wonder how it will work out) And I forgive them for their teasers because they are usually not insane like other teasers, and in my experience they believe in their mission: To educate, amuse, and enrich. Stock Gumshoe is so valuable to the human temperment, is very educational, and also is amusing- in a nice subtle way- laughing at human psychology. Thanks Travis
Picking stocks is like that old joke about the plumber who gives the client a $100. Bill. The customer becomes infuriated and yelled at him saying why are charging me $100. For spending about 10 minutes looking at my washing machington??? The plumber politely tells his customer I charged you $1 to hit the washing machine and $99. For knowing where to hit the washing machine. That’s what education and the Motley Fool are all about.
When I started out, I thought the fool’s word was gold, but soon realized, over time, it was fool’s gold.
I saw them seemingly pumping a stock one week and then bashing it the next. I paid closer attention and they do this unabashedly. So, do they pick winners in the weed sector? Do a very small amount of digging. You will find they pump the hell out of Canopy, pretty consistently. Aurora? It literally changes from day to day, week to week. I’ve seen articles warning people to sell aurora and run, one day, and a few days later, list it as one of the ‘three you had to buy’. They do this daily with a steadily changing rotation of 6-8 weed stocks, with WEED being the only one that they rarely bash.
I, personally, hate crap like that. They lost all credibility to me for this type of thing…
very wise. you understand that the METHOD of how you invest is far more consistent than the individual picks. Not many here understand that. I have never seen anyone invest profitably that does not out method before individual selections.
Warren Buffett never had a method. I just saw a documentary on his life.
PS my judgement of Travis and this service rivals my adoration of TMF.
m
KHRNF is a NEWER Marijuana stock that appears to have good potential going forward. Here is a link to the Chart: http://schrts.co/CZJgXh
I bought some KHRNF Khiron about 6 months ago, based on Ted Ohashi’s comments…..and added a bit more today.
This is a wonderful club you share information and hopefully make good good buys.
Thank you ggswift
$1499? What has Tom been smoking?
As I mentioned in some previous Stock Gumshoe articles about this new sector marijuana, As part of your due diligence, I suggest 3 weekly (free) enewsletters.
1. Let’s Toke Business Newsletter by Ted Ohashi. Send an email to Ted tedohashi@gmail.com and ask to be added to his newsletter and what country you are from.
2. http://www.newcannabisventures.com by Alan Brochstein
3. http://www.greenmarketreport.com
In addition, for serious cannabis investors, there is a microblog here on Stock Gumshoe “420 Investors” author is Gr8Full; don’t expect to have your inquiries answered, but do share your experiences.
Happy Investing!
Correction: 420 Investors author is Gr8Full! ….. I forgot the ! …… for those of you who might want to search for the Microblog.
#Microblog: 420 Investors
Well, my first opinion since becoming a member. I like the CBD market right now. Legal everywhere. NBEV is looking good to me, a little pricey, but their distribution of products in 46 states is impressive. CBD infused drinks will way out perform, in my humble opinion. I already use CBD on a daily basis, and it really helps my neck pain. I think the big companies will eat up most of theses companies are talking about. Coke, Pepsi, Phillip Morris, big alcohol. Just saying.
You should check out HIPH. They have the only hydrogen infused CBD water out there. The company and management look really good to me.
CBD is different than many other substances in that the bioavailability when taken orally is vastly lower than when vaped or smoked. 15 percent orally, compared to 50 to 60 percent from inhaled vapor. Vapor goes directly from lungs to blood stream, so it doesn’t have to be processed through the hepatic system to get there.
Pretty soon, consumers might find out that oral CBD is hardly more than a novelty. You can get actual relief from oral administration, but it takes much longer to kick in.
The only possible positive arguments for using oral CBD, would be if you hated money and felt you needed to get rid of it, blended with a love of waiting and wondering when relief will come, if at all. In comparison to inhaled vapor, it’s a total waste.
I’d personally only invest in good products that are not ridiculously inferior to other similar options.
Interesting, hadn’t heard that about CBD. Thanks for chiming in!
Finally a nice group of folks who are”honest” and not whipping up a story to sell something!!
I would NEVER buy the snake oil of Motley Retards